Vote outcome is binary: if dissidents win three seats, near-term sale or cash return becomes likely (bearish for long-term holders, bullish for short-term arbitrage). If management wins, status quo continues with ongoing cash burn and revenue decline. Monitor proxy advisor recommendations (ISS/Glass Lewis) and institutional holder votes for signal.
Price Chart
Executive Summary
Seer management filed two DEFA14A letters urging shareholders to vote FOR its seven director nominees at the July 28, 2026 annual meeting, rejecting activist Bradley Radoff and Michael Torok's attempt to replace three directors. Management argues the dissident nominees lack proteomics and life sciences tools experience, while the dissidents have previously proposed acquisition offers and criticized severe value destruction. The filings escalate the proxy fight ahead of the vote.
Key Financial Metrics
Key Facts
- Annual meeting scheduled for July 28, 2026; record date May 29, 2026.
- Activist group Radoff-JEC (7.8% owner) seeks to replace three directors: CEO/Chair Omid Farokhzad, Terrance McGuire, and Dipchand Nishar.
- Management claims dissident nominees lack proteomics, life sciences tools, and platform operating experience.
- Dissidents previously made three non-binding acquisition proposals (latest $2.40/share + CVR, 42% premium) which board rejected.
- Management recommends voting FOR all seven nominees on the BLUE proxy card.
- Cross-filing context: PREC14A filed 48d ago noted stock down ~97% since IPO, cumulative losses >$465M, Q1 revenue -34% YoY to $2.8M.
Financial Impact
Proxy fight with activist seeking board control; dissidents previously proposed $2.40/share + CVR acquisition (42% premium to then-price). No financial figures in this filing.
Risk Factors
- Dissident nominees could win board seats, leading to strategic shift or sale at potentially suboptimal price.
- Management's rejection of acquisition proposals may frustrate shareholders seeking liquidity.
- Continued cash burn ($15.7M/quarter) without path to profitability increases distress risk regardless of vote outcome.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (SEER) — Batch item 1 | 0001193125-26-298034 |
| Document: 0001193125-26-298034-index-headers.html | 0001193125-26-298033 |
| Document: 0001193125-26-298034-index.html | 0001193125-26-298034 |
| Document: 0001193125-26-298034.txt | 0001193125-26-298034 |
| DEFA14A Filing (SEER) — Batch item 5 | 0001193125-26-298033 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | Press Release | $1.97 | awaiting T+20 | — | $1.96 (−0.51%) |
Oct 15, 2026 13d ago | ITC Section 337 | $2.03 | awaiting T+20 | — | $1.96 (−3.45%) |
Oct 8, 2026 19d ago | 3 | $2.19 | awaiting T+20 | — | $1.96 (−10.50%) |
Sep 21, 2026 5w ago | Press Release | $1.86 $2.02 | ▲ +8.60% | ▲ +9.51% | $1.96 (+5.38%) |
Jul 31, 2026 12w ago | 8-K | $2.22 $1.98 | ▼ −10.81% | ▼ −13.80% | $1.96 (−11.71%) |
Jul 28, 2026 13w ago | Press Release | $2.08 $2.02 | ▲ +2.88% | ▲ +7.90% | $1.96 (+5.77%) |
Jul 28, 2026 13w ago | DFAN14A | $2.14 $2.04 | ▼ −4.67% | ▼ −8.05% | $1.96 (−8.41%) |
Jul 20, 2026 14w ago | DEFA14A | $2.04 $2.03 | ▼ −0.49% | ▼ −4.61% | $1.96 (−3.92%) |
Jul 20, 2026 14w ago | Press Release | $2.04 $2.03 | ▼ −0.49% | ▼ −4.61% | $1.96 (−3.92%) |
Jul 8, 2026 15w ago | DEFA14A | $2.18 $2.19 | ▲ +0.46% | ▼ −2.81% | $1.96 (−10.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers